Skip to Content
MicroorganismsMicroorganisms
  • Review
  • Open Access

15 October 2023

17 Pages

Advances in Vaporized Hydrogen Peroxide Reusable Medical Device Sterilization Cycle Development: Technology Review and Patent Trends

Chemical Engineering Department, Université Laval, 1065 Avenue de la Médecine, Quebec, QC G1V 0A6, Canada

Abstract

Vaporized hydrogen peroxide (VHP) terminal sterilization is one of the most promising techniques for sterilizing temperature-sensitive medical instruments like endoscopes. This technique requires only electricity and sterilant containers to perform the sterilization process in less than 1 h without any substantial safety concerns for patients, personnel, and the environment. This review studies recent advances and future trends in VHP sterilization cycle development using U.S. patent applications and 510(k) premarket notifications. In this regard, the patents focused on increasing VHP concentration or handling residual moisture are discussed in depth. The expired patents are analyzed to introduce existing unencumbered technologies, and active patents are presented to show the most current novelties and technology trends. In addition, 510(k) premarket notifications are explored to evaluate implemented technologies in US market-leading commercial products.

1. Introduction

The COVID-19 pandemic reminded us of the importance of the continuous improvement of medical technologies to fight against evolving pathogens. Incomplete sterilization of reusable medical instruments can be fatal, and sterilization must be followed properly before instrument reuse on a patient to reduce the probability of infection. Steam sterilization is one of the most common sterilization methods that operates around 121 °C, therefore, cannot be used for temperature-sensitive instruments like endoscopes made of polymeric parts which often cannot tolerate temperatures above 60 °C [1] or surgical instruments with delicate components. Ethylene oxide gas (EOG) sterilization is used mainly for industrial low-temperature sterilization of medical instruments and for hospital applications facing safety concerns for personnel, patients, and the environment, as well as long overall reprocessing time due to extended ventilation. Other chemical agents, like glutaraldehyde and formaldehyde, have been also used, respectively, mainly for high-level disinfection and general disinfection, but their application remained limited because of safety and efficacy considerations [2]. It is worth mentioning that the primary objective of sterilization is to completely eliminate or kill all forms of microorganisms and to make the item entirely free from viable microorganisms, rendering it sterile. Disinfection though aims to only reduce the number of microorganisms to a level that is considered safe for human health. Accordingly, reliable sterilization technologies are required to efficiently and safely sterilize temperature-sensitive medical instruments like endoscopes.
Advanced oxidation processes (AOPs) take advantage of highly reactive species, like hydroxyl radicals, which can rapidly and effectively degrade a wide range of organic and inorganic pollutants, including microorganisms. Though AOPs were first introduced for environmental remediation, they obtained attention in other industries, like the sterilization of medical devices, due to their high efficacy. Liquid hydrogen peroxide is one of the most common AOP agents, but its medical application has been generally limited to antiseptic and disinfectant. Vaporized hydrogen peroxide (VHP) demonstrated higher antimicrobial efficacy than its liquid form and could be used with a concentration as low as 1–10 mg/L [2]. This might be because of different mechanisms of action in the vapor phase [3] as well as its rapid penetration into diffusion-restricted environments in vacuum conditions. VHP sterilization application is growing rapidly due to a new revision of AAMI ST91, which suggests enhancing flexible endoscope reprocessing from high-level disinfection to sterilization [4]. VHP was also combined with other sterilization technologies, like plasma [5] or ozone [6], although, through time, VHP converted into the main sterilizing agent and the initial technology primarily plays the role of safety in removing the remaining hydrogen peroxide at the end of the sterilization process. VHP is compatible with most polymeric materials found in medical instruments like endoscopes. In addition, it demonstrated higher patient and healthcare worker safety in comparison to other gaseous oxidizing agents like EOG since it can degrade easily into water and oxygen. Stringent regulatory compliance, precise monitoring, and comprehensive training further bolster safety, making VHP sterilization a trusted and efficient method for safeguarding patients, personnel, and the environment in healthcare settings. VHP sterilization devices require only electricity and a sterilant container; they sterilize in less than 1 h and require no extended aeration. However, only bone-dry and non-cellulose-based medical instruments are compatible, and there are still compatibility issues for some materials like nylon.
In general, VHP sterilization is effective, safe, compatible, fast, and energy-efficient, particularly when compared to other sterilization methods. VHP’s efficacy is attributed to its ability to rapidly penetrate even diffusion-restricted environments, effectively killing microorganisms. Compared to traditional methods like steam sterilization, which cannot be used for temperature-sensitive instruments like endoscopes, VHP offers a versatile solution. It excels in achieving a high level of microbial reduction while also being compatible with most polymeric materials. Furthermore, VHP’s non-toxic by-products and minimal environmental impact make it a safer choice. Compared to alternatives like EOG, which can leave hazardous residues and require extended ventilation periods, VHP’s quick sterilization cycle and generation of nontoxic residues (water and oxygen) enhances both instrument safety and workflow efficiency. Furthermore, VHP can complete the sterilization process in less than one hour, making it notably faster than methods like steam sterilization, which require longer cycles, or EOG sterilization, which requires ventilation for several hours. Additionally, VHP operates at lower temperatures, reducing energy consumption and making it an energy-efficient choice in comparison to steam sterilization, which requires evaporation of extensive amounts of water, and EOG, which needs several hours of ventilation. On the other hand, due to significant constraints like scale, penetration, and compatibility with packaging materials, the widespread adoption of VHP sterilization for single-use devices has yet to obtain traction. Nevertheless, recent advancements in the sterilization chamber design and cycle development offer a fresh perspective and potential for exploration [7].
VHP sterilization for medical devices is subject to rigorous regulatory requirements, particularly in the United States, overseen by the Food and Drug Administration (FDA). Compliance involves adhering to recognized standards such as ANSI/AAMI ST58:2013 [8], and entails a meticulous validation process. Manufacturers must conduct validation studies demonstrating consistent microbial inactivation using biological indicators and routine monitoring of critical parameters. Continuous monitoring and validation are necessary to accommodate changes in cycle design, device design, and materials, ultimately safeguarding the safety and effectiveness of medical devices treated with VHP sterilization in healthcare settings.
Several VHP sterilization family devices have been approved by the FDA for sale in the US market, including STERRAD (Advanced Sterilization Products (ASP), Irvine, CA, USA), V-Pro (Steris, Inc., Mentor, OH, USA), PSD-85 (Sterilucent Inc., Minneapolis, MN, USA), and STERIZONE VP4 (Stryker Inc., Kalamazoo, MI, USA). Currently, STERRAD and V-Pro are the most widely used sterilizers in the US market. STERRAD 100NX and V-PRO maX are larger capacity hospital sterilizers, while STERRAD NX and V-PRO S are smaller devices with a lower chamber volume. From a hardware point of view, the main differences between STERRAD and V-PRO sterilization cycles are related to plasma generation, VHP concentration increase, and VHP concentration measurement. The cycles available in a single sterilizer model could only use a part of the hardware. For example, only STANDARD and FLEX cycles of STERRAD 100NX use a VHP concentrator, and only the DUO cycle uses a delivery module to temporarily hold hydrogen peroxide from a cassette and dispense a smaller amount of sterilant during each half-cycle.
In VHP sterilization devices, the sterilization cycle is typically composed of two identical half-cycles. The use of these half-cycles is often based on a method known as the “Overkill Approach”, as described in the ISO14937:2009 standard [9]. In this approach, a routine sterilant dwell period is extrapolated (to 12 spore log reduction) from the time required to achieve a 6-log reduction in a population of 106 biological indicators (BIs), ultimately providing a Sterility Assurance Level (SAL) of ≤10−6. This method assumes that the microbial inactivation kinetics follow a linear pattern, similar to what is observed in EOG sterilization of BIs like Bacillus atrophaeus (B. atrophaeus, ATCC 9372), as noted in ISO 11138-2 [10] for EOG. It relies on the assumption that microbial populations treated with VHP will exhibit the same resistance to the applied lethal stress, as represented by a log-linear inactivation kinetic plot, often using populations like Geobacillus stearothermophilus (ATCC 7953) or B. atrophaeus as Bis [11].
The VHP sterilization half-cycle usually consists of three main steps, namely conditioning, sterilization, and venting. The conditioning step aims to remove air from the load to facilitate the penetration of VHP as well as remove traces of moisture remaining on the load. The pressure at the end of the conditioning step is less than 1 Torr and in STERRAD sterilizers could produce plasma for up to 15 min to enhance moisture removal. During the sterilization step, which is the main part of the process, VHP is injected in a fixed amount (STERRAD and V-pro) or fixed differential pressure (STERIZONE VP4). Since the obtained pressure is higher than the dew point of hydrogen peroxide solution at ambient temperature (around 5 Torr [12,13]), a microlayer condensate forms on the load. This means that, contrary to popular belief, VHP condenses inside the chamber in these sterilizers. To enhance the sterility inside a diffusion-restricted environment, like lumens, the air is usually injected after VHP to deliver it into diffusion-restricted environments. The sterilization phase is repeated one or a few times to obtain an additional 6-log reduction of the resistant bacterial spore. During the venting step, which aims to enhance safety, the chamber is evacuated to transfer VHP to a catalytic converter and is then filled with fresh filtered air. As an example, cycle parameters of the Flexible cycle of V-PRO® maX 2 sterilizer are extracted from its Technical Data Monograph [14] and summarized in Table S1. In general, the configurations of STERRAD and V-Pro sterilization cycles are similar, with differences in the conditioning pressure (0.15–1 Torr), plasma time (0–15 min), amount and concentration of injected VHP (59–96%), the number of VHP injections (2 or 4), VHP post-injection pressure (6–14 Torr), duration of hold after VHP injection (1.5–6 min), after air injection (0.75–10 min), and target air injection pressure (760 or 500 Torr) [14,15,16,17]. To the best knowledge of the author, no review has been performed on the VHP sterilization cycle development.
In this work, the current developments and future trends of cycle development for VHP terminal sterilization are reviewed. In this way, special focus has been given to patent applications and 510(k) premarket notifications as the most reliable sources of information published by manufacturers.

3. Analysis of 510(k) Premarket Notification

A 510(k) premarket notification is a premarket submission made to the U.S. Food and Drug Administration (FDA) to demonstrate that a medical device is safe and effective, that is, substantially equivalent to a legally marketed device. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires device manufacturers to notify the FDA at least 90 days in advance of their intention to market a medical device in the United States. The 510(k) submission must include detailed information about the medical device, its intended use, and any similarities or differences to other devices already on the market. While the analysis of active patents provides a perspective on future potential advances in the VHP sterilization industry, studying 510(k) of FDA-cleared sterilizers is one of the most reliable sources of information about implemented technologies in commercial sterilizers. The 510(k) process primarily concerns devices intended for the U.S. market and it offers valuable insights into the evolving landscape of commercial sterilizers. The data obtained from 510(k) premarket notifications can shed light on the continuous improvement efforts undertaken by manufacturers to enhance user experiences and maintain the highest levels of quality assurance. This should be noted that 510(k) premarket notification may not be representative of medical devices sold outside the US, and national clearances could be studied to obtain information.
Table S2 summarizes 510(k) premarket notification clearances of STERRAD 100NX and NX, as well as V-Pro maX and S series sterilizers. Analysis of this table could clarify cycle modifications of cleared sterilizers. This table reveals most of the notifications extend the previous claims or aim in improving user experiences like software upgrades, graphical user interface enhancement, and network connectivity. No changes have been observed on the cycles after their clearance, which could be attributed to the enormous efforts required for verification and validation activities for numerous medical instruments. The only significant observed modification on the cycle is related to the addition of a load conditioning feature as a part of ALLClear Technology of the STERRAD® 100NX Sterilizer. This feature, which is only available in its Standard, Flex, and Express cycles, “reduces canceled cycles by performing load and system checks and executing a load conditioning step before starting a sterilization cycle” [38]. Since ALLClear Technology changes only the conditioning step and terminates cycles with problematic loads, it is claimed that the feature does not modify the existing sterilization cycles.

4. Conclusions

The development and improvement of sterilization technologies are crucial in reducing patient infections caused by evolving pathogens. VHP sterilization has emerged as a more reliable option than EOG sterilization for non-industrial applications involving temperature-sensitive medical instruments. Extensive patent research on VHP sterilization has focused on enhancing VHP concentration within the sterilization chamber or in diffusion-restricted environments, as well as addressing residual water concerns through detection or elimination methods.
Innovative approaches to increase VHP concentration inside the chamber have included techniques such as pre-concentration of VHP before injection, prime injection, and condensation on the load followed by re-evaporation. Patents targeting increased VHP concentration within diffusion-restricted environments, like lumens, have explored strategies such as air injection, stepwise air injection, attachment of lumens to empty or sterilant-containing vessels, and direct injection of VHP into lumens. Additionally, patents addressing residual moisture detection have utilized pressure monitoring during pressure hold, gas concentration monitoring, evacuation time differences, gas temperature differences during conditioning vacuum, local pressure maxima versus time diagrams during conditioning vacuum, and local maxima in the second derivative of pressure versus time diagrams during conditioning vacuum. Furthermore, patents focusing on residual moisture elimination have incorporated technologies like air plasma, ultrasonic wave vibration, and the injection of hot and/or dry air.
Analysis of 510(k) premarket notifications has revealed that many of these notifications aim to extend previous claims or enhance user experiences through software upgrades, graphical user interface improvements, and network connectivity. While these modifications may not directly impact the efficiency of sterilization cycles, they contribute to improved sterilization practices by reducing the likelihood of user errors and providing tools for more efficient supervision and management of tasks. Notably, ASP has introduced significant improvements to the VHP sterilization cycle in recent years, including NX technology for VHP concentration before injection and All Clear Technology for load and system checks, as well as the execution of a load conditioning step prior to initiating a sterilization cycle. While new VHP cycles have been introduced as supplementary options with slight parameter modifications (such as target pressure or duration of hold) to minimize risks associated with developing entirely new products, this approach can limit inventive thinking and impede fundamental improvements. It is essential to invest in in-depth research to obtain a better understanding of the complex simultaneous phenomena that occur during VHP sterilization, including phase equilibrium, fluid mechanics, heat transfer, mass transfer, and reaction kinetics under various environmental and load conditions. This review can pave the way for novel VHP sterilizers, enabling significant advancements.
Future research efforts should focus on developing technologies that increase the concentration of hydrogen peroxide inside diffusion-restricted environments like narrow and long lumens. This not only has the potential to expand the range of medical devices suitable for sterilization by VHP systems, but also reduce cycle duration, improve material compatibility, and minimize safety concerns. To achieve this, alternative pressure alteration patterns should be explored to maximize hydrogen peroxide penetration without compromising its concentration in the gaseous phase. Special attention should be given to the effect of air compression in the middle of the lumen as a worst-case condition. On the other hand, the direct injection of a sterilant into medical devices emerges as a promising approach. However, it is of utmost importance to exercise special care and attention to detail when sterilizing the contact point of the injection port with medical instruments. This meticulous approach ensures the effectiveness and safety of the sterilization process, safeguarding the integrity of the medical devices and maintaining their functionality. In addition to research efforts, collaborations between VHP sterilizer designers and medical device and packaging designers can play a vital role in enhancing VHP penetration into medical devices and packaging materials. By jointly optimizing designs and considering the unique requirements of both sterilization processes and the devices themselves, these partnerships can pave the way for improved sterilization efficacy and safety. Through close collaboration, manufacturers and designers can address challenges related to VHP concentration, pressure alterations, and the injection of sterilant into medical devices, ultimately driving advancements in the field.
In conclusion, continuous research and development efforts in VHP sterilization cycle technologies hold great promise for enhancing the sterilization of reusable medical devices. By addressing challenges related to hydrogen peroxide penetration inside diffusion-restricted environments like lumens, researchers can drive significant improvements in sterilization outcomes and contribute to advancements in the field. Rigorous testing and validation studies, in line with regulatory guidelines, are crucial to ensure the reliability and effectiveness of proposed technologies in real-world applications.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11102566/s1, Table S1: Summary of the parameters of Flexible cycle of V-PRO® maX 2 sterilizer; Table S2: Summary of 510(k) premarket notification clearances of STERRAD 100NX and NX as well as V-Pro Max and S series sterilizers.

Funding

This review received no external funding.

Acknowledgments

In Memoriam: Remembering Sooran Noroozi—This review paper is dedicated to the memory of Sooran Noroozi, an extraordinary individual whose life was tragically cut short on 31 July 2023. Noroozi exemplified exceptional strength, firm determination, and boundless kindness throughout his life, leaving a lasting impression on those fortunate enough to have known him. Noroozi’s lasting spirit serves as an inspiration to all who had the privilege of crossing his path. His pursuit of knowledge and academic excellence, reaching its peak with the completion of his Ph.D. thesis in chemical engineering, showed his dedication to advancing human understanding and making lives better. In honor of Sooran Noroozi’s remarkable journey and the challenges he faced with gracefulness and intrinsic strength, this paper stands as a remembrance of his memory. It is a reminder of the importance of persistence in the face of challenges and the lasting impact of a life well-lived. May his influence continue to inspire future generations of researchers and scholars to push the boundaries of knowledge and seek solutions to the most pressing challenges of our time.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Deprey, E.J.; Petersen, M.P.; Mosher, R.F. System for Decontamination of a Lumen Device. U.S. Patent 15,138,379, 7 May 2016. [Google Scholar]
  2. McDonnell, G.; Antloga, K.; Azad, S.; Robinson, N. Amsco® V-PRO™ 1: A new low temperature sterilisation system. ACORN 2008, 21, 10–16. [Google Scholar]
  3. Mc Donnell, G.; Burke, P.A. New low temperature sterilization processes. Int. J. Infect. Control 2009, 5. [Google Scholar] [CrossRef] [Scilit]
  4. AAMI/ANSI ST91:2021; American National Standards Institute and Association for the Advancement of Medical Instrumentation. Comprehensive Guidance to Flexible and Semi-Rigid Endoscope Processing in Health Care Facilities. AAMI: Arlington, VA, USA, 2021.
  5. Jacobs, P.T.; Lin, S.-M. Hydrogen Peroxide Plasma Sterilization System. U.S. Patent 06,747,209, 1987. [Google Scholar]
  6. Dufresne, S.; Martel, C.; Leblond, H.; Dassie, N.; Martel, K. Sterilization Method and Apparatus. U.S. Patent 13,779,132, 2016. [Google Scholar]
  7. McEvoy, B.; Eveland, R. Vaporized Hydrogen Peroxide: A Well-Known Technology with a New Application. Biomed. Instrum. Technol. 2020, 54, 74–79. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Association for the Advancement of Medical Instrumentation. ANSI/AAMI ST58: 2013 Chemical Sterilization and High-Level Disinfection in Health Care Facilities; American National Standard: Washington, DC, USA, 2013. [Google Scholar]
  9. ISO 14937:2009; Sterilization of Health Care Products—General Requirements for Characterization of a Sterilizing Agent and the Development, Validation, and Routine Control of a Sterilization Process for Medical Devices. ISO: Geneva, Switzerland, 2009.
  10. ISO 11138-2:2017; Sterilization of Health Care Products—Biological Indicators—Part 2: Biological Indicators for Ethylene Oxide Sterilization Processes. ISO: Geneva, Switzerland, 2017.
  11. McEvoy, B.; Rowan, N.J. Terminal sterilization of medical devices using vaporized hydrogen peroxide: A review of current methods and emerging opportunities. J. Appl. Microbiol. 2019, 127, 1403–1420. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Witte, M.; Eulogio, S. Method and Apparatus for Detecting Water Entrapment in a Vaccum Chamber. U.S. Patent 08,942,154, 5 October 1997. [Google Scholar]
  13. Laflamme, J.; Sohier, D.; Dufresne, S.; Chevalier, C.; Leblond, H.; Therrien, F. Sterilization Apparatus and Adaptive Control Thereof. U.S. Patent 16,105,351, 2020. [Google Scholar]
  14. STERIS. V-PRO® maX 2 Low Temperature Sterilization System; Technical Data Monograph in 10382631 Revolution B (M9454EN); STERIS: Mentor, OH, USA, 2018. [Google Scholar]
  15. Advanced Sterilization Products. STERRAD® 100NX® Sterilization System Service Guide; TS-54155-04; Advanced Sterilization Products: Metro Manila, Philippines,, 2011. [Google Scholar]
  16. STERIS. V-PRO® s2 Low Temperature Sterilization System; Technical Data Monograph in 10778508 Revolution A; STERIS: Mentor, OH, USA, 2019. [Google Scholar]
  17. U.S. Food and Drug Administration. 510(k) Premarket Notification of STERRAD 100NX STERILIZER, K071385. Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K071385 (accessed on 13 February 2023).
  18. Dougherty, E.F.; Hopkins, Q.G.; Sanborn, J.E.; Weibel, A.T. Tin (II) Stabilizer for Hydrogen Peroxide. U.S. Patent 50,786,72A, 7 January 1990. [Google Scholar]
  19. Jacobs, P.; Lin, S.-M.; Wang, J.-H.; Kohler, J.; Kendall, R.; Gamsarian, A. Sterilization System and Method and Inlet Control Apparatus Therefor. U.S. Patent 10,403,140, 7 August 2003. [Google Scholar]
  20. Wang, J.-H.; Jacobs, P.; Lin, S.-M. Process for Concentrating a Sterilant and Sterilizing Articles Therewith. U.S. Patent 09,474,142, 2 December 1999. [Google Scholar]
  21. Ahiska, F. “Sterilization with In-Line Concentrating and Injection of Hydrogen Peroxide”, Getinge Stericool Medikal Aletler Sanayi ve Ticaret AS. U.S. Patent 13,437,035, 14 January 2012. [Google Scholar]
  22. Prieve, J.F.; Jacobs, P.T.; Lin, S.-M.; Timmons, R.B. Method and Apparatus for Measuring the Concentration of Hydrogen Peroxide Vapor. U.S. Patent 09,337,727, 2001. [Google Scholar]
  23. Schenk, E.H.; Burke, P.A.; Centanni, M.A. Amperometric Gas Sensor. U.S. Patent 13,776,953, 2016. [Google Scholar]
  24. Wang, J.-H.; Lin, S.-M.; Jacobs, P.T. Sterilizing a Device by Revaporizing a Condensed Vapor. U.S. Patent 09,223,594, 6 January 2004. [Google Scholar]
  25. Kawasaki, K. Method of Decontamination and Decontamination Apparatus. U.S. Patent 11,381,903, 2006. [Google Scholar]
  26. Klobusnik, K.J. Method of Performing Sterilization Cycle. U.S. Patent 14,468,654, 2016. [Google Scholar]
  27. Childers, R.W.; Gagne, D.R. Method of Enhanced Penetration of Low Vapor Pressure Chemical Vapor Sterilants during Sterilization. U.S. Patent 07,973,372, 18 June 1996. [Google Scholar]
  28. Nowruzi, K.; Omidbakhsh, N. Apparatus and Method for Sterilizing Endoscope. U.S. Patent 15,198,670, 11 June 2019. [Google Scholar]
  29. Addy, T.O.; Jacobs, P.T.; Lin, S.-M.; Jacobs, J.M. Method of Sterilization in Diffusion Restricted Environments. U.S. Patent 08,833,375, 5 October 1997. [Google Scholar]
  30. Kowatsch, R.; Soto, T.; Howlett, C. Method for Vapor Sterilization of Articles Having Lumens. U.S. Patent 08,436,999, 31 March 1998. [Google Scholar]
  31. Wu, S.-S.; Williams, H.; Chu, N.; Strobel, H.; Lin, S.-M.; Hui, H.; Feldman, L. Lumen Sterilization Device and Method. U.S. Patent 11,743,227, 2007. [Google Scholar]
  32. Conseil, P.; Chicatun, F. Apparatus and Method for Sterilization of an Article. U.S. Patent 16,349,945, 2022. [Google Scholar]
  33. Truong, D.V.; Morrison, T. Apparatus and Method for Detecting Moisture in a Vacuum Chamber. U.S. Patent 16,666,888, 2023. [Google Scholar]
  34. McLaren, J.; Olson, S.J.; Larson, K. Apparatus and Method for Drying and Sterilizing Objects in a Load. U.S. Patent 13,526,872, 31 July 2012. [Google Scholar]
  35. Sheth, V.B.; Upchurch, D.C. Method of Detecting Liquid in a Sterilization System. U.S. Patent 07,850,941, 7 June 1992. [Google Scholar]
  36. Wu, S.-S.S.; Chu, N.S.; Merhazion, A. Method of Enhanced Sterilization with Improved Material Compatibility. U.S. Patent 09,470,246, 2 April 1999. [Google Scholar]
  37. Yardimci, O.; Solomon, A.M.; Mallory, P.S.; Jesurun, D. Method for Removing Moisture from a Container. U.S. Patent 13,796,019, 4 February 2013. [Google Scholar]
  38. Lee, W. Low Temperature Sterilizer Having Chamber of Which Volume Is Variable; CUBE Instrument Inc.: Daejeon, Republic of Korea, 2017. [Google Scholar] [CrossRef]
  39. Spencer, R.M.; Addy, T.O. Plasma-Enhanced Vacuum Drying. U.S. Patent 08,320,932, 1997. [Google Scholar]
  40. Eveland, R.W. Apparatus and Method for Sterilizing Material. U.S. Patent 16,562,516, 2023. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.